Partnership in cardiovascular medicine

ثبت نشده
چکیده

Through several years of work within the Board of the European Society of Cardiology (ESC), we have become increasingly aware of an issue of growing importance for the future, not only for the Society but also for other actors within the framework of cardiovascular medicine, partnership. Thus, we would like to express our thoughts on partnership between professional organizations, healthcare providers and governments, and the medical industry. The ESC was founded in 1950, when most of the diagnostic and therapeutic possibilities that are today’s norms were not available and, in many cases, not even imagined. The Society was founded at a time of great hope for the future. Technological and other innovations, partly derived from the war industry, became fundamental for medical progress. Representatives from 14 National Societies of Cardiology appreciated the importance of joint efforts, and created the embryo of the ESC. From then on, the Society grew into a large and powerful organization, highly respected within the profession and by the medical industry, particularly after creation of the Scientific Working Groups in 1976, the administrative office in 1986, and annual congresses since 1989. The platform of the Society, co-operation between National Societies of cardiologists and Scientific Working Groups, became consolidated and the annual congress rapidly grew into a global event. Subsequently in 1993, the European Heart House, our headquarters, was inaugurated at Sophia Antipolis in southern France.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Trans-Pacific Partnership: Should We “Fear the Fear”?; Comment on “The Trans-Pacific Partnership: Is It Everything We Feared for Health?”

RLabonté et al entitle their paper in this issue of the International Journal of Health Policy and Management “The Trans-Pacific Partnership: Is It Everything We Feared for Health?” Tantalisingly, they do not directly answer the question they pose, and in this commentary, we suggest that it is the wrong question; we should not ‘fear’ the Trans-Pacific Partnership (TPP) at all, rather we should ...

متن کامل

Challenges of public-private partnership model in public hospitals in Yazd

Introduction: Despite many challenges, public-private partnership in hospitals is recognized as one of the most attractive investment platforms for the private sector. This study conducted to assess the challenges of private sector partnership with public hospitals using the public-private partnership model in public hospitals in Yazd. Methods: The present qualitative research conducted in 202...

متن کامل

Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative; Comment on “The Trans-Pacific Partnership: Is It Everything We Feared for Health?”

In this commentary, we endorse concerns about the health impact of the trans-pacific partnership (TPP), paying particular attention to its mechanisms for investor state dispute settlement. We then describe the different, judgeled approach being advocated by the European Commission team negotiating the Trans-Atlantic Trade and Investment Partnership, arguing that, while not perfect, it offers si...

متن کامل

A Partnership Model for Improving Service Delivery in Remote Papua New Guinea: A Mixed Methods Evaluation

Background The Community Mine Continuation Agreement Middle (CMCA) and South Fly Health Program (the Health Program) is a partnership for improving health service delivery in remote Papua New Guinea (PNG). The Health Program is delivered by a private contractor working in partnership with existing health service providers to improve service delivery using existing government systems, where poss...

متن کامل

Autologous Stem Cell in CHF(When is more effective?) Intracoronary Administration of Autologous Bone Marrow Stem Cell in Chronic Heart Failure

Introduction: We aimed at evaluating the clinical, laboratory and echocardiography effects of intracoronary administration of autologous bone marrow stem cell transplantation in different clinical entities of chronic Heart Failure (HF) patients.   Methods: This procedure was carried out during an interventional study conducted in the Cardiology department from JAN 2012 to APR 2013. The HF ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2001